Clinerion Ltd

Clinerion, a wholly owned subsidiary of TriNetX LLC, accelerates clinical research and medical access to treatments for patients. We use proprietary, patented technologies for analysis of live electronic health record (EHR) data from our global network of partner hospitals to generate real-world data (RWD), which can be used for investigation into disease epidemiology, the patient journey and outcomes, and patient care metrics. Clinerion's Patient Network Explorer platform radically improves the efficiency and effectiveness of clinical trials by offering data-driven protocol optimization, site feasibility evaluation, and search and identification for patient recruitment – in real-time. Among other uses, we provide solutions for increasing diversity in clinical trials and identification of rare disease patients. Clinerion’s new Federated Machine Learning Platform enables the training and validation of machine learning (ML) algorithms on our global RWD network. Apart from the contributions to drug development this platform targets to develop preventive care for patients before they reach a critical stage. Clinerion operates on the principle of “privacy by design” and complies fully with international patient privacy and data security regulations. Clinerion is headquartered in Switzerland. Clinerion website: www.clinerion.com Clinerion’s Patient Network Explorer: www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer

Website

http://www.clinerion.com

Externer Link zu Clinerion Ltd

Branche

IT-Dienstleistungen und IT-Beratung

Größe

11–50 Beschäftigte

Hauptsitz

Basel, Basel-Town

Art

Privatunternehmen

Gegründet

2008

Spezialgebiete

Patient Search, Market Access, Precision Medicine, Real-world Evidence, Rare Diseases, Orphan Drugs, Patient Identification, Site Selection, Protocol Validation, Clinical Trials, machine learning, artificial intelligence und real-world data